GS
PASG icon

GTS Securities’s Passage Bio PASG Stock Holding History

GTS Securities’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.8K Buy
+10,000
New +$62.6K ﹤0.01% 1275

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

GTS Securities's PASG Position: Q2 2026 in Review

GTS Securities opened a new position in Passage Bio (PASG) in Q2 2026: 10,000 shares worth $48.8K. The stake represents ﹤0.01% of the portfolio and ranks #1275 among its holdings.

29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • GTS Securities held 10,000 shares of Passage Bio worth $48.8K as of Q2 2026.
  • Passage Bio was a new GTS Securities position in Q2 2026.
  • Passage Bio made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1275 holding.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.